Latest Share Chat

E-therapeutics Share News (ETX)

E-therapeutics Information

Buy ETX Shares
Add ETX to Watchlist
Add ETX to Alert

Share Price Information for E-therapeutics (ETX)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 9.00

Bid: 9.00

Ask: 9.50

Change: -0.65 (-6.74%)

Spread: 0.50 (5.556%)

Open: 9.50

High: 10.20

Low: 9.00

Prev. Close: 9.65

Last checked at -

e-Therapeutics raises GBP23 million to expand capability and pipeline

Fri, 14th May 2021 09:48

(Alliance News) - e-Therapeutics PLC on Friday said it has closed a share placing, subscription and retail offer via PrimaryBid, raising GBP22.5 million gross.

The Oxford, England-based drug discovery company said it will issue a total of 93.8 million shares at a price of 24 pence each.

AIM-listed e-Therapeutics shares were trading 7.0% lower in London on Friday morning at 25.40p each, giving it a market capitalisation of GBP106.9 million.

The proceeds of the fundraising will go towards several initiatives, including expanding the company's proprietary, disease-agnostic, drug discovery and development platform capabilities and asset pipeline.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

More News

2 Jul 2021 13:47

E-therapeutics meets 'key milestone' in Galapagos collaboration

(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.

9 Jun 2021 16:08

UK shareholder meetings calendar - next 7 days

2 Jun 2021 16:02

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

2 Jun 2021 09:42

E-therapeutics brings in Alison Gallafent as head of IP

(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.

14 May 2021 14:20

E-therapeutics raises £22.5m to expand capabilities and pipeline

(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.

14 May 2021 10:23

Latest Share Chat

E-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

e-Therapeutics raises GBP23 million to expand capability and pipeline

E-therapeutics meets 'key milestone' in Galapagos collaboration

UK shareholder meetings calendar - next 7 days

EXECUTIVE CHANGES: CEO departs after GLI Finance becomes Sancus

E-therapeutics brings in Alison Gallafent as head of IP

E-therapeutics raises £22.5m to expand capabilities and pipeline

AIM WINNERS & LOSERS: Velocity and Physiomics boosted by contract wins

IN BRIEF: e-Therapeutics to raise GBP20 million to expand capability

TRADING UPDATES: Profit rises for Griffin Mining, Jersey Electricity

AIM WINNERS & LOSERS: PHSC plans share buyback as earnings rise

UK earnings, trading statements calendar - next 7 days

AIM WINNERS & LOSERS: Bigblu Broadband rises on Quickline stake sale

e-Therapeutics gets two payments from Galapagos under collaboration

E-therapeutics to receive two milestone payments from Galapagos

EXECUTIVE CHANGES: F&C Investment Trust hires CBI chief economist

Latest Share Chat

E-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

e-Therapeutics raises GBP23 million to expand capability and pipeline

Login to your account

Quickpicks are a member only feature

Login to your account